FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Antero Kesäniemi

Research Profile

Geographic Areas

Finland

Concepts & Ideas

Chemicals & Drugs

Physiology

Disorders

Procedures

Case Control Studies

Genes & Molecular Sequences

Alleles

Co-author Network

Publications

TOP 3
Aki S Havulinna; Antti Jula; Y Antero Kesäniemi; Johannes Kettunen; Kimmo Kontula; Clive Osmond; Leena Peltonen; Veikko Salomaa; Olavi Ukkola; Johan G Eriksson; Christopher Newton-Cheh
A blood pressure genetic risk score is a significant predictor of incident cardiovascular events in 32 669 individuals.
Elina Malo; Merja Santaniemi; Meiju Saukko; Olavi Ukkola; Roberto Blanco Sequeiros; Mirella Hietaniemi; Eveliina Lammentausta; Y Antero Kesäniemi
Plasma lipid levels and body weight altered by intrauterine growth restriction and postnatal fructose diet in adult rats.
Olli T Raitakari; Veikko Salomaa; Markku J Savolainen; Tiina Solakivi; Jouko Sundvall; Jorma S A Viikari; Salim Yusuf; Sonia S Anand; Minna L Hannuksela; Jussi Hernesniemi; Matti Jauhiainen; Antti Jula; Markus Juonala; Mika Kähönen; Y Antero Kesäniemi; Petri T Kovanen; Terho Lehtimäki; Jaana Leiviskä; Britt-Marie Loo; Ville-Petteri Mäkinen; Jukka Marniemi; Matthew J McQueen; Ruby Miller; Jaakko Niemi; Markku Peltonen; Mika Ala-Korpela
Computationally estimated apolipoproteins B and A1 in predicting cardiovascular risk.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Antero Kesäniemi (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Aki S Havulinna; Antti Jula; Y Antero Kesäniemi; Johannes Kettunen; Kimmo Kontula; Clive Osmond; Leena Peltonen; Veikko Salomaa; Olavi Ukkola; Johan G Eriksson; Christopher Newton-Cheh
A blood pressure genetic risk score is a significant predictor of incident cardiovascular events in 32 669 individuals.
Hypertension 2013;61(5):987-94.
2013: Elina Malo; Merja Santaniemi; Meiju Saukko; Olavi Ukkola; Roberto Blanco Sequeiros; Mirella Hietaniemi; Eveliina Lammentausta; Y Antero Kesäniemi
Plasma lipid levels and body weight altered by intrauterine growth restriction and postnatal fructose diet in adult rats.
Pediatric research 2013;73(2):155-62.
2013: Olli T Raitakari; Veikko Salomaa; Markku J Savolainen; Tiina Solakivi; Jouko Sundvall; Jorma S A Viikari; Salim Yusuf; Sonia S Anand; Minna L Hannuksela; Jussi Hernesniemi; Matti Jauhiainen; Antti Jula; Markus Juonala; Mika Kähönen; Y Antero Kesäniemi; Petri T Kovanen; Terho Lehtimäki; Jaana Leiviskä; Britt-Marie Loo; Ville-Petteri Mäkinen; Jukka Marniemi; Matthew J McQueen; Ruby Miller; Jaakko Niemi; Markku Peltonen; Mika Ala-Korpela
Computationally estimated apolipoproteins B and A1 in predicting cardiovascular risk.
Atherosclerosis 2013;226(1):245-51.
2013: A W Turunen; Antti Jula; Mika Kähönen; H Karanko; Y Antero Kesäniemi; Hannu Kiviranta; S Männistö; J Marniemi; Leena Moilanen; Markku S Nieminen; A L Suominen; Pekka Tiittanen; Pia Verkasalo
Fish consumption, omega-3 fatty acids, and environmental contaminants in relation to low-grade inflammation and early atherosclerosis.
Environmental research 2013;120():43-54.
2012: Riitta-Liisa Vasunta; Antti S Ylitalo; Y Antero Kesäniemi; Olavi H Ukkola
High ambulatory blood pressure values associated with non-alcoholic fatty liver in middle-aged adults.
Journal of hypertension 2012;30(10):2015-9.
2012: Pauliina Pisto; Merja Santaniemi; Juha-Pekka Turpeinen; Olavi Ukkola; Y Antero Kesäniemi
Adiponectin concentration in plasma is associated with muscle fiber size in healthy middle-aged men.
Scandinavian journal of clinical and laboratory investigation 2012;72(5):395-402.
2012: Juha Pekka Räisänen; Marja-Leena Silaste; Y Antero Kesäniemi; Olavi Ukkola
Increased daily sodium intake is an independent dietary indicator of the metabolic syndrome in middle-aged subjects.
Annals of medicine 2012;44(6):627-34.
2012: Eeva Hookana; M Juhani Junttila; Kari S Kaikkonen; Y Antero Kesäniemi; Marja-Leena Kortelainen; Olavi Ukkola; Heikki V Huikuri
Comparison of family history of sudden cardiac death in nonischemic and ischemic heart disease.
Circulation. Arrhythmia and electrophysiology 2012;5(4):757-61.
2012: Olavi Ukkola; T Pääkkö; Y Antero Kesäniemi
Ghrelin and its promoter variant associated with cardiac hypertrophy.
Journal of human hypertension 2012;26(7):452-7.
2012: Kalle Sipilä; Marjut Varpula; Markku Päivänsalo; Antti Reunanen; Veikko Salomaa; Antti Jula; Risto Kaaja; Mika Kähönen; Hannu Karanko; Y Antero Kesäniemi; Leena Moilanen
Carotid artery intima-media thickness and elasticity in relation to glucose tolerance.
Acta diabetologica 2012;49(3):215-23.
2012: James D Best; Timothy M E Davis; Paul L Drury; Anthony C Keech; Y Antero Kesäniemi; Christopher Pardy; Russell Scott; Marja-Riitta Taskinen; Merryn Voysey
Glycemic control over 5 years in 4,900 people with type 2 diabetes: real-world diabetes therapy in a clinical trial cohort.
Diabetes care 2012;35(5):1165-70.
2012: Ingar Holme; Y Antero Kesäniemi; William Malbecq; Terje R Pedersen; Simon Ray; Anne B Rossebø; Kristian Wachtell; Ronnie Willenheimer; Kurt Boman; Kenneth Egstrup; Eva Gerdts; Christa Gohlke-Bärwolf
A risk score for predicting mortality in patients with asymptomatic mild to moderate aortic stenosis.
Heart (British Cardiac Society) 2012;98(5):377-83.
2012: Anders M Greve; Y Antero Kesäniemi; Lars Køber; Christoph Nienaber; Simon Ray; Anne B Rossebø; Kurt Boman; Richard B Devereux; Kenneth Egstrup; Christa Gohlke-Baerwolf; Ronnie Willenheimer; Kristian Wachtell
Clinical implications of electrocardiographic left ventricular strain and hypertrophy in asymptomatic patients with aortic stenosis: the Simvastatin and Ezetimibe in Aortic Stenosis study.
Circulation 2012;125(2):346-53.
2012: Tuija J Huusko; Sakari Kakko; Y Antero Kesäniemi; Merja Santaniemi; Markku J Savolainen; Panu Taskinen; Olavi Ukkola; Tuire M Salonurmi
Long telomeres in blood leukocytes are associated with a high risk of ascending aortic aneurysm.
PloS one 2012;7(11):e50828.
2011: Pauliina Pisto; Merja Santaniemi; Olavi Ukkola; Y Antero Kesäniemi
Plasma adiponectin--an independent indicator of liver fat accumulation.
Metabolism: clinical and experimental 2011;60(11):1515-20.
2011: Elina Malo; Olavi Ukkola; Maarit Jokela; Leena Moilanen; Mika Kähönen; Markku S Nieminen; Veikko Salomaa; Antti Jula; Y Antero Kesäniemi
Resistin is an indicator of the metabolic syndrome according to five different definitions in the Finnish Health 2000 survey.
Metabolic syndrome and related disorders 2011;9(3):203-10.
2011: J Jylhävä; A Haarala; Mika Kähönen; Terho Lehtimäki; Antti Jula; Leena Moilanen; Y Antero Kesäniemi; Markku S Nieminen; Mikko Hurme
Pentraxin 3 (PTX3) is associated with cardiovascular risk factors: the Health 2000 Survey.
Clinical and experimental immunology 2011;164(2):211-7.
2011: Nikolaus Jander; Jan Minners; Ingar Holme; Eva Gerdts; Kurt Boman; Philippe Brudi; John B Chambers; Kenneth Egstrup; Y Antero Kesäniemi; William Malbecq; Christoph A Nienaber; Simon Ray; Anne Rossebø; Terje R Pedersen; Terje Skjaerpe; Ronnie Willenheimer; Kristian Wachtell; Franz-Josef Neumann; Christa Gohlke-Bärwolf
Outcome of patients with low-gradient "severe" aortic stenosis and preserved ejection fraction.
Circulation 2011;123(8):887-95.
2011: K Luotola; A Pietilä; T Zeller; Leena Moilanen; Mika Kähönen; Markku S Nieminen; Y Antero Kesäniemi; S Blankenberg; Antti Jula; Markus Perola; Veikko Salomaa
Associations between interleukin-1 (IL-1) gene variations or IL-1 receptor antagonist levels and the development of type 2 diabetes.
Journal of internal medicine 2011;269(3):322-32.
2010: Eva Gerdts; Anne Bjørhovde Rossebø; Terje R Pedersen; Kurt Boman; Philippe Brudi; John Boyd Chambers; Kenneth Egstrup; Christa Gohlke-Bärwolf; Ingar Holme; Y Antero Kesäniemi; William Malbecq; Christoph Nienaber; Simon Ray; Terje Skjaerpe; Kristian Wachtell; Ronnie Willenheimer
Impact of baseline severity of aortic valve stenosis on effect of intensive lipid lowering therapy (from the SEAS study).
The American journal of cardiology 2010;106(11):1634-9.
2010: Meiju Saukko; Y Antero Kesäniemi; Olavi Ukkola
Leptin receptor Lys109Arg and Gln223Arg polymorphisms are associated with early atherosclerosis.
Metabolic syndrome and related disorders 2010;8(5):425-30.
2010: R L Vasunta; Y Antero Kesäniemi; Olavi Ukkola
Plasma adiponectin concentration is associated with ambulatory daytime systolic blood pressure but not with the dipping status.
Journal of human hypertension 2010;24(8):545-51.
2010: Juhani Vartiainen; Ulla Rajala; Jari Jokelainen; Sirkka Keinänen-Kiukaanniemi; Y Antero Kesäniemi; Olavi Ukkola
Serum ghrelin and the prediction of the development of impaired glucose regulation and Type 2 diabetes in middle-aged subjects.
Journal of endocrinological investigation 2010;33(7):496-500.
2010: Ingar Holme; Kurt Boman; Philippe Brudi; Kenneth Egstrup; Christa Gohlke-Baerwolf; Y Antero Kesäniemi; William Malbecq; Anne B Rossebø; Kristian Wachtell; Ronnie Willenheimer; Terje R Pedersen
Observed and predicted reduction of ischemic cardiovascular events in the Simvastatin and Ezetimibe in Aortic Stenosis trial.
The American journal of cardiology 2010;105(12):1802-8.
2010: Maritta Sämpi; Marja Veneskoski; Olavi Ukkola; Y Antero Kesäniemi; Sohvi Hörkkö
High plasma immunoglobulin (Ig) A and low IgG antibody titers to oxidized low-density lipoprotein are associated with markers of glucose metabolism.
The Journal of clinical endocrinology and metabolism 2010;95(5):2467-75.
2010: H Kastarinen; R-L Vasunta; O Ukkola; Y Antero Kesäniemi
Glomerular filtration rate is related to dipping pattern in ambulatory blood pressure monitoring--a cross-sectional population-based study.
Journal of human hypertension 2010;24(4):247-53.
2010: Tero Pääkkö; Olavi Ukkola; Markku Ikäheimo; Y Antero Kesäniemi
Plasma adiponectin levels are associated with left ventricular hypertrophy in a random sample of middle-aged subjects.
Annals of medicine 2010;42(2):131-7.
2010: David C Burgess; David Hunt; Liping Li; Diana Zannino; Elizabeth Williamson; Timothy Davis; Markku Laakso; Y Antero Kesäniemi; Jun Zhang; Raymond W Sy; Seppo Lehto; Stewart Mann; Anthony C Keech
Incidence and predictors of silent myocardial infarction in type 2 diabetes and the effect of fenofibrate: an analysis from the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study.
European heart journal 2010;31(1):92-9.
2009: Eija Kellokoski; Outi Kummu; Raisa Serpi; Petri Lehenkari; Olavi Ukkola; Y Antero Kesäniemi; Sohvi Hörkkö
Ghrelin vaccination decreases plasma MCP-1 level in LDLR(-/-)-mice.
Peptides 2009;30(12):2292-300.
2009: Antti Riikola; Kalle Sipilä; Mika Kähönen; Antti Jula; Markku S Nieminen; Leena Moilanen; Y Antero Kesäniemi; Terho Lehtimäki; Janne Hulkkonen
Interleukin-6 promoter polymorphism and cardiovascular risk factors: the Health 2000 Survey.
Atherosclerosis 2009;207(2):466-70.
2009: Kari Luotola; Rauni Pääkkönen; Mervi Alanne; Timo Lanki; Leena Moilanen; Ida Surakka; Arto Pietilä; Mika Kähönen; Markku S Nieminen; Y Antero Kesäniemi; Annette Peters; Antti Jula; Markus Perola; Veikko Salomaa
Association of variation in the interleukin-1 gene family with diabetes and glucose homeostasis.
The Journal of clinical endocrinology and metabolism 2009;94(11):4575-83.
2009: Olavi Ukkola; Riitta-Liisa Vasunta; Y Antero Kesäniemi
Non-dipping pattern in ambulatory blood pressure monitoring is associated with metabolic abnormalities in a random sample of middle-aged subjects.
Hypertension research : official journal of the Japanese Society of Hypertension 2009;32(11):1022-7.
2009: Eija Kellokoski; Anne Kunnari; Maarit Jokela; Sanna Mäkelä; Y Antero Kesäniemi; Sohvi Hörkkö
Ghrelin and obestatin modulate early atherogenic processes on cells: enhancement of monocyte adhesion and oxidized low-density lipoprotein binding.
Metabolism: clinical and experimental 2009;58(11):1572-80.
2009: Anne M Kunnari; Eeva-Riitta Savolainen; Olavi H Ukkola; Y Antero Kesäniemi; Maarit A Jokela
The expression of human resistin in different leucocyte lineages is modulated by LPS and TNFalpha.
Regulatory peptides 2009;157(1-3):57-63.
2009: Helena Kastarinen; Olavi Ukkola; Y Antero Kesäniemi
Glomerular filtration rate is related to carotid intima-media thickness in middle-aged adults.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2009;24(9):2767-72.
2009: Helena Kastarinen; Sohvi Hörkkö; Heikki Kauma; Anna Karjalainen; Markku Savolainen; Y Antero Kesäniemi
Low-density lipoprotein clearance in patients with chronic renal failure.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2009;24(7):2131-5.
2009: M Sämpi; Olavi Ukkola; Markku Päivänsalo; Y Antero Kesäniemi; Sohvi Hörkkö
Early atherosclerosis and IgG2 to bacteria are associated with FcgammaRIIa genotype in non-smokers.
European journal of clinical investigation 2009;39(6):517-26.
2009: Kalle Sipilä; Leena Moilanen; Tuomo Nieminen; Antti Reunanen; Antti Jula; Veikko Salomaa; Risto Kaaja; Katriina Kukkonen-Harjula; Terho Lehtimäki; Y Antero Kesäniemi; Teemu Koivistoinen; Markku S Nieminen; Jaakko Tuomilehto; Mika Kähönen
Metabolic syndrome and carotid intima media thickness in the Health 2000 Survey.
Atherosclerosis 2009;204(1):276-81.
2009: Hua Ling; Dawn M Waterworth; Heide A Stirnadel; Toni I Pollin; Philip J Barter; Y Antero Kesäniemi; Robert W Mahley; Ruth McPherson; Gérard Waeber; Thomas P Bersot; Jonathan C Cohen; Scott M Grundy; Vincent E Mooser; Braxton D Mitchell
Genome-wide linkage and association analyses to identify genes influencing adiponectin levels: the GEMS Study.
Obesity (Silver Spring, Md.) 2009;17(4):737-44.
2009: Mirella Hietaniemi; Elina Malo; Maarit Jokela; Merja Santaniemi; Olavi Ukkola; Y Antero Kesäniemi
The effect of energy restriction during pregnancy on obesity-related peptide hormones in rat offspring.
Peptides 2009;30(4):705-9.
2009: Piia Leskelä; Olavi Ukkola; Juhani Vartiainen; Tapani Rönnemaa; Jaakko Kaprio; Claude Bouchard; Y Antero Kesäniemi
Fasting plasma total ghrelin concentrations in monozygotic twins discordant for obesity.
Metabolism: clinical and experimental 2009;58(2):174-9.
2009: Mirella Hietaniemi; Merja Santaniemi; Elina Malo; Olavi Ukkola; Y Antero Kesäniemi; Maarit Jokela
Gene expression profiles in fetal and neonatal rat offspring of energy-restricted dams.
Journal of nutrigenetics and nutrigenomics 2009;2(4-5):173-83.
2009: Jaakko Niemi; Ville-Petteri Mäkinen; Jukka Heikkonen; Leena Tenkanen; Yrjö Hiltunen; Minna L Hannuksela; Matti Jauhiainen; Carol Forsblom; Marja-Riitta Taskinen; Y Antero Kesäniemi; Markku Savolainen; Kimmo Kaski; Per-Henrik Groop; Petri T Kovanen; Mika Ala-Korpela
Estimation of VLDL, IDL, LDL, HDL2, apoA-I, and apoB from the Friedewald inputs--apoB and IDL, but not LDL, are associated with mortality in type 1 diabetes.
Annals of medicine 2009;41(6):451-61.
2009: L Haukkamaa; L Moilanen; A Kattainen; Riitta Luoto; M Kahonen; Maija Leinonen; A Jula; Y Antero Kesäniemi; Risto Kaaja
Pre-eclampsia is a risk factor of carotid artery atherosclerosis.
Cerebrovascular diseases (Basel, Switzerland) 2009;27(6):599-607.
2009: Olavi Ukkola; Anne Kunnari; Maarit Jokela; Markku Päivänsalo; Y Antero Kesäniemi
ApoE phenotype is associated with inflammatory markers in middle-aged subjects.
Inflammation research : official journal of the European Histamine Research Society ... [et al.] 2009;58(1):54-9.
2008: Anne Kunnari; Merja Santaniemi; Maarit Jokela; Anna H Karjalainen; Jorma Heikkinen; Olavi Ukkola; Y Antero Kesäniemi
Estrogen replacement therapy decreases plasma adiponectin but not resistin in postmenopausal women.
Metabolism: clinical and experimental 2008;57(11):1509-15.
2008: Maritta Sämpi; Olavi Ukkola; Markku Päivänsalo; Y Antero Kesäniemi; Christoph J Binder; Sohvi Hörkkö
Plasma interleukin-5 levels are related to antibodies binding to oxidized low-density lipoprotein and to decreased subclinical atherosclerosis.
Journal of the American College of Cardiology 2008;52(17):1370-8.
2008: Anne B Rossebø; Terje R Pedersen; Kurt Boman; Philippe Brudi; John B Chambers; Kenneth Egstrup; Eva Gerdts; Christa Gohlke-Bärwolf; Ingar Holme; Y Antero Kesäniemi; William Malbecq; Christoph A Nienaber; Simon Ray; Terje Skjaerpe; Kristian Wachtell; Ronnie Willenheimer
Intensive lipid lowering with simvastatin and ezetimibe in aortic stenosis.
The New England journal of medicine 2008;359(13):1343-56.
2008: Nilesh J Samani; Olli T Raitakari; Kalle Sipilä; Martin D Tobin; Heribert Schunkert; Markus Juonala; Peter Braund; Jeanette Erdmann; Jorma Viikari; Leena Moilanen; Leena Taittonen; Antti Jula; Eero Jokinen; Tomi Laitinen; Nina Hutri-Kähönen; Markku S Nieminen; Y Antero Kesäniemi; Alistair Hall; Janne Hulkkonen; Mika Kähönen; Terho Lehtimäki
Coronary artery disease-associated locus on chromosome 9p21 and early markers of atherosclerosis.
Arteriosclerosis, thrombosis, and vascular biology 2008;28(9):1679-83.
2008: Heikki Luukinen; Jari Jokelainen; Kari Kervinen; Y Antero Kesäniemi; Satu Winqvist; Matti Hillbom
Risk of dementia associated with the ApoE epsilon4 allele and falls causing head injury without explicit traumatic brain injury.
Acta neurologica Scandinavica 2008;118(3):153-8.
2008: Olavi Ukkola; Anne Kunnari; Y Antero Kesäniemi
Genetic variants at the resistin locus are associated with the plasma resistin concentration and cardiovascular risk factors.
Regulatory peptides 2008;149(1-3):56-9.
2008: Kirsti Jalovaara; Merja Santaniemi; Markku Timonen; Jari Jokelainen; Y Antero Kesäniemi; Olavi Ukkola; Sirkka Keinänen-Kiukaanniemi; Ulla Rajala
Low serum adiponectin level as a predictor of impaired glucose regulation and type 2 diabetes mellitus in a middle-aged Finnish population.
Metabolism: clinical and experimental 2008;57(8):1130-4.
2008: Heide Stirnadel; Xiwu Lin; Hua Ling; Kijoung Song; Philip Barter; Y Antero Kesäniemi; Robert Mahley; Ruth McPherson; Gerard Waeber; Thomas Bersot; Jonathan Cohen; Scott Grundy; Braxton D Mitchell; Vincent Mooser; Dawn Waterworth
Genetic and phenotypic architecture of metabolic syndrome-associated components in dyslipidemic and normolipidemic subjects: the GEMS Study.
Atherosclerosis 2008;197(2):868-76.
2008: Heli Koukkunen; Veikko Salomaa; Seppo Lehto; Matti Ketonen; Pirjo Immonen-Räihä; Aapo Lehtonen; Aki Havulinna; Y Antero Kesäniemi; Kalevi Pyörälä
Coronary events in persons aged 75 years or older in Finland from 1995 to 2002: the FINAMI study.
The American journal of geriatric cardiology 2008;17(2):78-86.
2008: Manjinder S Sandhu; Dawn M Waterworth; Sally L Debenham; Eleanor Wheeler; Konstantinos Papadakis; Jing Hua Zhao; Kijoung Song; Xin Yuan; Toby Johnson; Sofie Ashford; Michael Inouye; Robert Luben; Matthew Sims; David Hadley; Wendy L McArdle; Philip Barter; Y Antero Kesäniemi; Robert W Mahley; Ruth McPherson; Scott M Grundy; Sheila A Bingham; Kay-Tee Khaw; Ruth J F Loos; Gérard Waeber; Inês Barroso; David P Strachan; Panos Deloukas; Peter Vollenweider; Nicholas J Wareham; Vincent Mooser
LDL-cholesterol concentrations: a genome-wide association study.
Lancet 2008;371(9611):483-91.
2008: Olavi Ukkola; Seppo M Pöykkö; Markku Päivänsalo; Y Antero Kesäniemi
Interactions between ghrelin, leptin and IGF-I affect metabolic syndrome and early atherosclerosis.
Annals of medicine 2008;40(6):465-73.
2007: Olavi Ukkola; Y Antero Kesäniemi
Leptin and high-sensitivity C-reactive protein and their interaction in the metabolic syndrome in middle-aged subjects.
Metabolism: clinical and experimental 2007;56(9):1221-7.
2007: Olavi Ukkola; Y Antero Kesäniemi
Leu7Pro polymorphism of PreproNPY associated with an increased risk for type II diabetes in middle-aged subjects.
European journal of clinical nutrition 2007;61(9):1102-5.
2007: Teemu J Niiranen; Antti Jula; Ilkka Kantola; Leena Moilanen; Mika Kähönen; Y Antero Kesäniemi; Markku S Nieminen; Antti Reunanen
Home-measured blood pressure is more strongly associated with atherosclerosis than clinic blood pressure: the Finn-HOME Study.
Journal of hypertension 2007;25(6):1225-31.
2007: Philip J Barter; Y Ruth McPherson; Kijoung Song; Y Antero Kesäniemi; Robert W Mahley; Gérard Waeber; Thomas P Bersot; Vincent Mooser; Dawn M Waterworth; Scott M Grundy
Serum insulin and inflammatory markers in overweight individuals with and without dyslipidemia.
The Journal of clinical endocrinology and metabolism 2007;92(6):2041-5.
2007: A Majuri; Merja Santaniemi; Katrina Rautio; Anne Kunnari; Juhani Vartiainen; Aimo Ruokonen; Y Antero Kesäniemi; Juha S Tapanainen; Olavi Ukkola; Laure Morin-Papunen
Rosiglitazone treatment increases plasma levels of adiponectin and decreases levels of resistin in overweight women with PCOS: a randomized placebo-controlled study.
European journal of endocrinology / European Federation of Endocrine Societies 2007;156(2):263-9.
2007: Hanna-Riikka Lehto; Seppo Lehto; Aki S Havulinna; Matti Ketonen; Aapo Lehtonen; Y Antero Kesäniemi; Juhani Airaksinen; Veikko Salomaa
Are coronary event rates declining slower in women than in men - evidence from two population-based myocardial infarction registers in Finland?
BMC cardiovascular disorders 2007;7():35.
2006: Merja Santaniemi; Y Antero Kesäniemi; Olavi Ukkola
Low plasma adiponectin concentration is an indicator of the metabolic syndrome.
European journal of endocrinology / European Federation of Endocrine Societies 2006;155(5):745-50.
2006: Juhani Vartiainen; Y Antero Kesäniemi; Olavi Ukkola
Sequencing analysis of ghrelin gene 5' flanking region: relations between the sequence variants, fasting plasma total ghrelin concentrations, and body mass index.
Metabolism: clinical and experimental 2006;55(10):1420-5.
2006: Veikko Salomaa; Matti Ketonen; Heli Koukkunen; Pirjo Immonen-Räihä; Aapo Lehtonen; Jorma Torppa; Kari Kuulasmaa; Y Antero Kesäniemi; Kalevi Pyörälä
The effect of correcting for troponins on trends in coronary heart disease events in Finland during 1993-2002: the FINAMI study.
European heart journal 2006;27(20):2394-9.
2006: Matti Vanhanen; Keijo Koivisto; Leena Moilanen; Eeva-Liisa Helkala; Tuomo Hänninen; Hilkka Soininen; Kari Kervinen; Y Antero Kesäniemi; Markku Laakso; Johanna Kuusisto
Association of metabolic syndrome with Alzheimer disease: a population-based study.
Neurology 2006;67(5):843-7.
2006: Anu Tuominen; Yury I Miller; Lotte F Hansen; Y Antero Kesäniemi; Joseph L Witztum; Sohvi Hörkkö
A natural antibody to oxidized cardiolipin binds to oxidized low-density lipoprotein, apoptotic cells, and atherosclerotic lesions.
Arteriosclerosis, thrombosis, and vascular biology 2006;26(9):2096-102.
2006: Seppo M Pöykkö; Eija Kellokoski; Olavi Ukkola; Heikki Kauma; Markku Päivänsalo; Y Antero Kesäniemi; Sohvi Hörkkö
Plasma ghrelin concentrations are positively associated with carotid artery atherosclerosis in males.
Journal of internal medicine 2006;260(1):43-52.
2006: Anne Kunnari; Olavi Ukkola; Markku Päivänsalo; Y Antero Kesäniemi
High plasma resistin level is associated with enhanced highly sensitive C-reactive protein and leukocytes.
The Journal of clinical endocrinology and metabolism 2006;91(7):2755-60.
2006: J-P Turpeinen; J Leppävuori; Olli Heinonen; K Kaila; J Salo; M Lilja; Y Antero Kesäniemi
Muscle fiber type I influences lipid oxidation during low-intensity exercise in moderately active middle-aged men.
Scandinavian journal of medicine & science in sports 2006;16(2):134-40.
2006: Johanna Salonen; Y Antero Kesäniemi; Olavi Ukkola
Association between angiotensin-converting enzyme insertion/deletion polymorphism and treatment response in type 2 diabetic patients.
European journal of internal medicine 2006;17(2):115-9.
2006: Anna Kattainen; Veikko Salomaa; Tommi Härkänen; Antti Jula; Risto Kaaja; Y Antero Kesäniemi; Mika Kähönen; Leena Moilanen; Markku S Nieminen; Arpo Aromaa; Antti Reunanen
Coronary heart disease: from a disease of middle-aged men in the late 1970s to a disease of elderly women in the 2000s.
European heart journal 2006;27(3):296-301.
2006: Eeva H Linna; Juha S Perkiömäki; Mari Karsikas; Tapio Seppänen; Markku Savolainen; Y Antero Kesäniemi; Timo H Mäkikallio; Heikki V Huikuri
Functional significance of KCNH2 (HERG) K897T polymorphism for cardiac repolarization assessed by analysis of T-wave morphology.
Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc 2006;11(1):57-62.
2005: Pia Pajunen; Heli Koukkunen; Matti Ketonen; Tapani Jerkkola; Pirjo Immonen-Räihä; Päivi Kärjä-Koskenkari; Kari Kuulasmaa; Pertti Palomäki; J Mustonen; A Lehtonen; Matti Arstila; Tapio Vuorenmaa; Seppo Lehto; H Miettinen; Jorma Torppa; Jaakko Tuomilehto; Y Antero Kesäniemi; Kalevi Pyörälä; Veikko Salomaa
Myocardial infarction in diabetic and non-diabetic persons with and without prior myocardial infarction: the FINAMI Study.
Diabetologia 2005;48(12):2519-24.
2005: Olavi Ukkola; J Salonen; Y Antero Kesäniemi
Role of candidate genes in the lipid responses to intensified treatment in Type 2 diabetes.
Journal of endocrinological investigation 2005;28(10):871-5.
2005: Pia Pajunen; Heli Koukkunen; Matti Ketonen; Tapani Jerkkola; Pirjo Immonen-Räihä; Päivi Kärjä-Koskenkari; Markku Mähönen; M Niemelä; Kari Kuulasmaa; Pertti Palomäki; J Mustonen; A Lehtonen; Matti Arstila; Tapio Vuorenmaa; S Lehto; H Miettinen; A Juolevi; Jorma Torppa; Jaakko Tuomilehto; Y Antero Kesäniemi; K Pyörälä; V Salomaa
Five-year risk of developing clinical diabetes after first myocardial infarction; the FINAMI study.
Diabetic medicine : a journal of the British Diabetic Association 2005;22(10):1334-7.
2005: Yi Yu; Diego F Wyszynski; Dawn M Waterworth; Steven D Wilton; Philip J Barter; Y Antero Kesäniemi; Robert W Mahley; Ruth McPherson; Gérard Waeber; Thomas P Bersot; Qianli Ma; Sanjay S Sharma; Douglas S Montgomery; Lefkos T Middleton; Scott S Sundseth; Vincent Mooser; Scott M Grundy; Lindsay A Farrer
Multiple QTLs influencing triglyceride and HDL and total cholesterol levels identified in families with atherogenic dyslipidemia.
Journal of lipid research 2005;46(10):2202-13.
2005: Veikko Salomaa; Heli Koukkunen; Matti Ketonen; Pirjo Immonen-Räihä; Päivi Kärjä-Koskenkari; Juha Mustonen; Seppo Lehto; Jorma Torppa; Aapo Lehtonen; Jaakko Tuomilehto; Y Antero Kesäniemi; Kalevi Pyörälä
A new definition for myocardial infarction: what difference does it make?
European heart journal 2005;26(17):1719-25.
2005: Anne Maria Koivisto; Seppo Helisalmi; Jussi Pihlajamäki; Leena Moilanen; Johanna Kuusisto; Markku Laakso; Mikko Hiltunen; Koivisto Keijo; Tuomo Hänninen; Eeva-Liisa Helkala; Kari Kervinen; Y Antero Kesäniemi; Hilkka Soininen
Interleukin-6 promoter polymorphism and late-onset Alzheimer's disease in the Finnish population.
Journal of neurogenetics 2005;19(3-4):155-61.
2005: Olavi Ukkola; Tuomo Rankinen; Timo A Lakka; Arthur S Leon; James Skinner; Jack H Wilmore; Dabeeru C Rao; Y Antero Kesäniemi; Claude Bouchard
Protein tyrosine phosphatase 1B variant associated with fat distribution and insulin metabolism.
Obesity research 2005;13(5):829-34.
2005: Eija Kellokoski; Seppo M Pöykkö; Anna H Karjalainen; Olavi Ukkola; Jorma Heikkinen; Y Antero Kesäniemi; Sohvi Hörkkö
Estrogen replacement therapy increases plasma ghrelin levels.
The Journal of clinical endocrinology and metabolism 2005;90(5):2954-63.
2005: Anne Kunnari; Olavi Ukkola; Y Antero Kesäniemi
Resistin polymorphisms are associated with cerebrovascular disease in Finnish Type 2 diabetic patients.
Diabetic medicine : a journal of the British Diabetic Association 2005;22(5):583-9.
2005: Pia Pajunen; Heli Koukkunen; Matti Ketonen; Tapani Jerkkola; Pirjo Immonen-Räihä; Päivi Kärjä-Koskenkari; Markku Mähönen; Matti Niemelä; Kari Kuulasmaa; Pertti Palomäki; Juha Mustonen; Aapo Lehtonen; Matti Arstila; Tapio Vuorenmaa; Seppo Lehto; Heikki Miettinen; Jorma Torppa; Jaakko Tuomilehto; Y Antero Kesäniemi; Kalevi Pyörälä; Veikko Salomaa
The validity of the Finnish Hospital Discharge Register and Causes of Death Register data on coronary heart disease.
European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology 2005;12(2):132-7.
2005: Seppo M Pöykkö; Olavi Ukkola; Heikki Kauma; Eija Kellokoski; Sohvi Hörkkö; Y Antero Kesäniemi
The negative association between plasma ghrelin and IGF-I is modified by obesity, insulin resistance and type 2 diabetes.
Diabetologia 2005;48(2):309-16.
2005: Heikki Luukinen; Petteri Viramo; M Herala; Kari Kervinen; Y Antero Kesäniemi; Olli Savola; Satu Winqvist; Jari Jokelainen; Matti Hillbom
Fall-related brain injuries and the risk of dementia in elderly people: a population-based study.
European journal of neurology : the official journal of the European Federation of Neurological Societies 2005;12(2):86-92.
2005: Diego F Wyszynski; Dawn M Waterworth; Philip J Barter; Jonathan Cohen; Y Antero Kesäniemi; Robert W Mahley; Ruth McPherson; Gérard Waeber; Thomas P Bersot; Sanjay S Sharma; Vikki G Nolan; Lefkos T Middleton; Scott S Sundseth; Lindsay A Farrer; Vincent Mooser; Scott M Grundy
Relation between atherogenic dyslipidemia and the Adult Treatment Program-III definition of metabolic syndrome (Genetic Epidemiology of Metabolic Syndrome Project).
The American journal of cardiology 2005;95(2):194-8.
2005: Olavi Ukkola; Merja Santaniemi; Tuomo Rankinen; Arthur S Leon; James Skinner; Jack H Wilmore; D C Rao; Richard Bergman; Y Antero Kesäniemi; Claude Bouchard
Adiponectin polymorphisms, adiposity and insulin metabolism: HERITAGE family study and Oulu diabetic study.
Annals of medicine 2005;37(2):141-50.
2004: Juha T Karvonen; Heikki Kauma; Markku Päivänsalo; Y Antero Kesäniemi
Paraoxonase-1 gene Leu-Met55 and Gln-Arg192 polymorphisms are not associated with carotid artery atherosclerosis in a population-based cohort.
European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology 2004;11(6):511-2.
2004: Mohamed A Elrayess; Karen E Webb; Geoff J Bellingan; Ros A Whittall; Jahangir Kabir; Emma Hawe; Mikko Syvänne; Marja-Riitta Taskinen; M Heikki Frick; Markku S Nieminen; Y Antero Kesäniemi; Amos Pasternack; George J Miller; Steve E Humphries
R643G polymorphism in PECAM-1 influences transendothelial migration of monocytes and is associated with progression of CHD and CHD events.
Atherosclerosis 2004;177(1):127-35.
2004: Merja Santaniemi; Olavi Ukkola; Y Antero Kesäniemi
Tyrosine phosphatase 1B and leptin receptor genes and their interaction in type 2 diabetes.
Journal of internal medicine 2004;256(1):48-55.
2004: M J Junttila; M J Pekka Raatikainen; J Karjalainen; Heikki Kauma; Y Antero Kesäniemi; Heikki V Huikuri
Prevalence and prognosis of subjects with Brugada-type ECG pattern in a young and middle-aged Finnish population.
European heart journal 2004;25(10):874-8.
2004: Juhani Vartiainen; Seppo M Pöykkö; Tuija Räisänen; Y Antero Kesäniemi; Olavi Ukkola
Sequencing analysis of the ghrelin receptor (growth hormone secretagogue receptor type 1a) gene.
European journal of endocrinology / European Federation of Endocrine Societies 2004;150(4):457-63.
2004: Olavi Ukkola; Y Antero Kesäniemi; A Tremblay; C Bouchard
Two variants in the resistin gene and the response to long-term overfeeding.
European journal of clinical nutrition 2004;58(4):654-9.
2004: Raine Virtanen; Antti Jula; Heikki V Huikuri; Tom A Kuusela; Hans Helenius; Antti Ylitalo; Liisa-Maria Voipio-Pulkki; Heikki Kauma; Y Antero Kesäniemi; Juhani Airaksinen
Increased pulse pressure is associated with reduced baroreflex sensitivity.
Journal of human hypertension 2004;18(4):247-52.
2004: Philippa J Talmud; Steve Martin; Marja-Riitta Taskinen; M Heikki Frick; Markku S Nieminen; Y Antero Kesäniemi; Amos Pasternack; Steve E Humphries; Mikko Syvänne
APOA5 gene variants, lipoprotein particle distribution, and progression of coronary heart disease: results from the LOCAT study.
Journal of lipid research 2004;45(4):750-6.
2004: Anna H Karjalainen; Heikki Ruskoaho; Olli Vuolteenaho; Jorma Heikkinen; Ann-Christine Bäckström; Markku Savolainen; Y Antero Kesäniemi
Effects of estrogen replacement therapy on natriuretic peptides and blood pressure.
Maturitas 2004;47(3):201-8.
2004: Marja-Leena Silaste; Maire Rantala; Georg Alfthan; Antti Aro; Joseph L Witztum; Y Antero Kesäniemi; Sohvi Hörkkö
Changes in dietary fat intake alter plasma levels of oxidized low-density lipoprotein and lipoprotein(a).
Arteriosclerosis, thrombosis, and vascular biology 2004;24(3):498-503.
2004: Mikko Syvänne; Ros A Whittall; Ursula Turpeinen; Markku S Nieminen; M Heikki Frick; Y Antero Kesäniemi; Amos Pasternack; Steve E Humphries; Marja-Riitta Taskinen
Serum homocysteine concentrations, gemfibrozil treatment, and progression of coronary atherosclerosis.
Atherosclerosis 2004;172(2):267-72.
2003: Juha T Karvonen; Markku Päivänsalo; Y Antero Kesäniemi; Sohvi Hörkkö
Immunoglobulin M type of autoantibodies to oxidized low-density lipoprotein has an inverse relation to carotid artery atherosclerosis.
Circulation 2003;108(17):2107-12.
2003: Seppo M Pöykkö; Eija Kellokoski; Sohvi Hörkkö; Heikki Kauma; Y Antero Kesäniemi; Olavi Ukkola
Low plasma ghrelin is associated with insulin resistance, hypertension, and the prevalence of type 2 diabetes.
Diabetes 2003;52(10):2546-53.
2003: Olavi Ukkola; Y Antero Kesäniemi
Preproghrelin Leu72Met polymorphism in patients with type 2 diabetes mellitus.
Journal of internal medicine 2003;254(4):391-4.
2003: Veikko Salomaa; Matti Ketonen; Heli Koukkunen; Pirjo Immonen-Räihä; Tapani Jerkkola; Päivi Kärjä-Koskenkari; Markku Mähönen; M Niemelä; Kari Kuulasmaa; Pertti Palomäki; J Mustonen; Matti Arstila; Tapio Vuorenmaa; A Lehtonen; Seppo Lehto; H Miettinen; Jorma Torppa; Jaakko Tuomilehto; Y Antero Kesäniemi; Kalevi Pyörälä
Decline in out-of-hospital coronary heart disease deaths has contributed the main part to the overall decline in coronary heart disease mortality rates among persons 35 to 64 years of age in Finland: the FINAMI study.
Circulation 2003;108(6):691-6.
2003: Sakari Kakko; Markku Päivänsalo; Pirjo Koistinen; Y Antero Kesäniemi; Vuokko L Kinnula; Markku Savolainen
The signal sequence polymorphism of the MnSOD gene is associated with the degree of carotid atherosclerosis.
Atherosclerosis 2003;168(1):147-52.
2003: Mohamed A Elrayess; Karen E Webb; David M Flavell; Mikko Syvänne; Marja-Riitta Taskinen; M Heikki Frick; Markku S Nieminen; Y Antero Kesäniemi; Amos Pasternack; J Wouter Jukema; John J P Kastelein; Aeilko H Zwinderman; Steve E Humphries
A novel functional polymorphism in the PECAM-1 gene (53G>A) is associated with progression of atherosclerosis in the LOCAT and REGRESS studies.
Atherosclerosis 2003;168(1):131-8.
2003: Seppo M Pöykkö; Olavi Ukkola; Heikki Kauma; Markku Savolainen; Y Antero Kesäniemi
Ghrelin Arg51Gln mutation is a risk factor for Type 2 diabetes and hypertension in a random sample of middle-aged subjects.
Diabetologia 2003;46(4):455-8.
2003: Philippa J Talmud; Steve Martin; George Steiner; David M Flavell; David Whitehouse; Sylvia Nagl; Richard Jackson; Marja-Riitta Taskinen; M Heikki Frick; Markku S Nieminen; Y Antero Kesäniemi; Amos Pasternack; Steve E Humphries; Mikko Syvänne
Progression of atherosclerosis is associated with variation in the alpha1-antitrypsin gene.
Arteriosclerosis, thrombosis, and vascular biology 2003;23(4):644-9.
2003: Marja-Leena Silaste; Maire Rantala; Georg Alfthan; Antti Aro; Y Antero Kesäniemi
Plasma homocysteine concentration is decreased by dietary intervention.
The British journal of nutrition 2003;89(3):295-301.
2003: Veikko Salomaa; Matti Ketonen; Heli Koukkunen; Pirjo Immonen-Räihä; Tapani Jerkkola; Päivi Kärjä-Koskenkari; Markku Mähönen; M Niemelä; Kari Kuulasmaa; Pertti Palomäki; Matti Arstila; Tapio Vuorenmaa; Aapo Lehtonen; Seppo Lehto; H Miettinen; Jorma Torppa; Jaakko Tuomilehto; Y Antero Kesäniemi; Kalevi Pyörälä
Trends in coronary events in Finland during 1983-1997. The FINAMI study.
European heart journal 2003;24(4):311-9.
2003: Sakari Kakko; Jani Kelloniemi; Peter von Rohr; Ina Hoeschele; Minna Tamminen; Margaret E Brousseau; Y Antero Kesäniemi; Markku Savolainen
ATP-binding cassette transporter A1 locus is not a major determinant of HDL-C levels in a population at high risk for coronary heart disease.
Atherosclerosis 2003;166(2):285-90.
2003: Vesa Jokinen; Olavi Ukkola; K E Juhani Airaksinen; Juhani Koistinen; Markku Ikäheimo; Y Antero Kesäniemi; Heikki V Huikuri
Temporal changes in cardiovascular autonomic regulation in type II diabetic patients: association with coronary risk variables and progression of coronary artery disease.
Annals of medicine 2003;35(3):216-23.
2002: Juha T Karvonen; Heikki Kauma; Kari Kervinen; Olavi Ukkola; Maire Rantala; Markku Päivänsalo; Markku Savolainen; Y Antero Kesäniemi
Apolipoprotein E polymorphism affects carotid artery atherosclerosis in smoking hypertensive men.
Journal of hypertension 2002;20(12):2371-8.
2002: Vesa Karttunen; G Alfthan; Liisa Hiltunen; Vesa Rasi; Kari Kervinen; Y Antero Kesäniemi; Matti Hillbom
Risk factors for cryptogenic ischaemic stroke.
European journal of neurology : the official journal of the European Federation of Neurological Societies 2002;9(6):625-32.
2002: Maire Rantala; Marja-Leena Silaste; Anu Tuominen; Jari Kaikkonen; Jukka T Salonen; Georg Alfthan; Antti Aro; Y Antero Kesäniemi
Dietary modifications and gene polymorphisms alter serum paraoxonase activity in healthy women.
The Journal of nutrition 2002;132(10):3012-7.
2002: Iris Erlund; Marja-Leena Silaste; Georg Alfthan; M Rantala; Y Antero Kesäniemi; Antti Aro
Plasma concentrations of the flavonoids hesperetin, naringenin and quercetin in human subjects following their habitual diets, and diets high or low in fruit and vegetables.
European journal of clinical nutrition 2002;56(9):891-8.
2002: Eeva Pietilä; Heidi Fodstad; Elmo Niskasaari; Päivi J Laitinen P; Heikki Swan; Markku Savolainen; Y Antero Kesäniemi; Kimmo Kontula; Heikki V Huikuri
Association between HERG K897T polymorphism and QT interval in middle-aged Finnish women.
Journal of the American College of Cardiology 2002;40(3):511-4.
2002: David M Flavell; Yalda Jamshidi; Emma Hawe; Inés Pineda Torra; Marja-Riitta Taskinen; M Heikki Frick; Markku S Nieminen; Y Antero Kesäniemi; Amos Pasternack; Bart Staels; George Miller; Steve E Humphries; Philippa J Talmud; Mikko Syvänne
Peroxisome proliferator-activated receptor alpha gene variants influence progression of coronary atherosclerosis and risk of coronary artery disease.
Circulation 2002;105(12):1440-5.
2002: Juha T Karvonen; Heikki Kauma; Kari Kervinen; Maire Rantala; Markku Ikäheimo; Markku Päivänsalo; Markku Savolainen; Y Antero Kesäniemi
Endothelial nitric oxide synthase gene Glu298Asp polymorphism and blood pressure, left ventricular mass and carotid artery atherosclerosis in a population-based cohort.
Journal of internal medicine 2002;251(2):102-10.
2001: Marja-Leena Silaste; Maire Rantala; M Sämpi; Georg Alfthan; Antti Aro; Y Antero Kesäniemi
Polymorphisms of key enzymes in homocysteine metabolism affect diet responsiveness of plasma homocysteine in healthy women.
The Journal of nutrition 2001;131(10):2643-7.
2001: Sakari Kakko; Minna Tamminen; Markku Päivänsalo; Heikki Kauma; AO Rantala; M Lilja; A Reunanen; Y Antero Kesäniemi; Markku Savolainen
Variation at the cholesteryl ester transfer protein gene in relation to plasma high density lipoproteins cholesterol levels and carotid intima-media thickness.
European journal of clinical investigation 2001;31(7):593-602.
2001: Fredrik Karpe; Marja-Riitta Taskinen; Markku S Nieminen; M Heikki Frick; Y Antero Kesäniemi; Amos Pasternack; Anders Hamsten; Mikko Syvänne
Remnant-like lipoprotein particle cholesterol concentration and progression of coronary and vein-graft atherosclerosis in response to gemfibrozil treatment.
Atherosclerosis 2001;157(1):181-7.
2001: Olavi Ukkola; P H Erkkilä; Markku Savolainen; Y Antero Kesäniemi
Lack of association between polymorphisms of catalase, copper-zinc superoxide dismutase (SOD), extracellular SOD and endothelial nitric oxide synthase genes and macroangiopathy in patients with type 2 diabetes mellitus.
Journal of internal medicine 2001;249(5):451-9.
2001: Matti Vanhanen; Miia Kivipelto; Keijo Koivisto; Johanna Kuusisto; Leena Mykkänen; Eeva-Liisa Helkala; Tuomo Hänninen; Kari Kervinen; Y Antero Kesäniemi; Mikko P Laakso; Hilkka Soininen; Markku Laakso
APOE-epsilon4 is associated with weight loss in women with AD: a population-based study.
Neurology 2001;56(5):655-9.
2001: Anna H Karjalainen; M Paassilta; Jorma Heikkinen; Ann-Christine Bäckström; Markku Savolainen; Y Antero Kesäniemi
Effects of peroral and transdermal oestrogen replacement therapy on glucose and insulin metabolism.
Clinical endocrinology 2001;54(2):165-73.
2000: M Niemi; Kari Kervinen; Heikki Kiviniemi; Olavi Lukkarinen; Atte P Kyllönen; Meeri Apaja-Sarkkinen; Markku Savolainen; MI Kairaluoma; Y Antero Kesäniemi
Apolipoprotein E phenotype, cholesterol and breast and prostate cancer.
Journal of epidemiology and community health 2000;54(12):938-9.
2000: Anne Maria Koivisto; P Lempiäinen; Keijo Koivisto; Eeva-Liisa Helkala; Leena Mykkänen; Johanna Kuusisto; Kari Kervinen; Y Antero Kesäniemi; Markku Laakso; Hilkka Soininen
Apolipoprotein E phenotype alone does not influence survival in Alzheimer's disease: a population-based longitudinal study.
Neuroepidemiology 2000;19(6):327-32.
2000: AO Rantala; M Lilja; Heikki Kauma; Markku Savolainen; A Reunanen; Y Antero Kesäniemi
Gamma-glutamyl transpeptidase and the metabolic syndrome.
Journal of internal medicine 2000;248(3):230-8.
2000: Anna H Karjalainen; Jorma Heikkinen; Markku Savolainen; Ann-Christine Bäckström; Y Antero Kesäniemi
Regulation of plasma low density lipoprotein levels in postmenopausal women.
Atherosclerosis 2000;151(2):559-66.
2000: Anna H Karjalainen; Jorma Heikkinen; Markku Savolainen; Ann-Christine Bäckström; Y Antero Kesäniemi
Mechanisms regulating LDL metabolism in subjects on peroral and transdermal estrogen replacement therapy.
Arteriosclerosis, thrombosis, and vascular biology 2000;20(4):1101-6.
2000: Marja-Leena Silaste; R Junes; AO Rantala; Heikki Kauma; M Lilja; Markku Savolainen; A Reunanen; Y Antero Kesäniemi
Dietary and other non-pharmacological treatments in patients with drug-treated hypertension and control subjects.
Journal of internal medicine 2000;247(3):318-24.
2000: M Paassilta; Anna H Karjalainen; Kari Kervinen; Markku Savolainen; Jorma Heikkinen; Ann-Christine Bäckström; Y Antero Kesäniemi
Insulin-like growth factor binding protein-1 (IGFBP-1) and IGF-I during oral and transdermal estrogen replacement therapy: relation to lipoprotein(a) levels.
Atherosclerosis 2000;149(1):157-62.
2000: Maire Rantala; T T Rantala; Markku Savolainen; Y Friedlander; Y Antero Kesäniemi
Apolipoprotein B gene polymorphisms and serum lipids: meta-analysis of the role of genetic variation in responsiveness to diet.
The American journal of clinical nutrition 2000;71(3):713-24.
2000: Antti Ylitalo; K E Juhani Airaksinen; A Hautanen; Markku Kupari; M Carson; Juha Virolainen; Markku Savolainen; Heikki Kauma; Y Antero Kesäniemi; Perrin C White; Heikki V Huikuri
Baroreflex sensitivity and variants of the renin angiotensin system genes.
Journal of the American College of Cardiology 2000;35(1):194-200.
2000: Sakari Kakko; Minna Tamminen; Markku Päivänsalo; Heikki Kauma; AO Rantala; M Lilja; A Reunanen; Y Antero Kesäniemi; Markku Savolainen
Cholesteryl ester transfer protein gene polymorphisms are associated with carotid atherosclerosis in men.
European journal of clinical investigation 2000;30(1):18-25.
1999: T Korhonen; Markku Savolainen; Y Antero Kesäniemi
Variation of apolipoprotein B as a possible cause of decreased low density lipoprotein clearance and hypercholesterolemia.
Atherosclerosis 1999;146(1):1-10.
1999: M Niemi; Kari Kervinen; AO Rantala; Heikki Kauma; Markku Päivänsalo; Markku Savolainen; M Lilja; Y Antero Kesäniemi
The role of apolipoprotein E and glucose intolerance in gallstone disease in middle aged subjects.
Gut 1999;44(4):557-62.
1999: M Passilta; Kari Kervinen; Y Antero Kesäniemi
Glucose metabolism, insulin-like growth factor-I, and insulin-like growth factor-binding protein-1 after alcohol withdrawal.
Alcoholism, clinical and experimental research 1999;23(3):471-5.
1999: T Korhonen; Minna L Hannuksela; Seppo Seppänen; Kari Kervinen; Y Antero Kesäniemi; Markku Savolainen
The effect of the apolipoprotein E phenotype on cholesteryl ester transfer protein activity, plasma lipids and apolipoprotein A I levels in hypercholesterolaemic patients on colestipol and lovastatin treatment.
European journal of clinical pharmacology 1999;54(12):903-10.
1999: Vilmundur Gudnason; Sakari Kakko; V Nicaud; Markku Savolainen; Y Antero Kesäniemi; Esa Tahvanainen; S Humphries
Cholesteryl ester transfer protein gene effect on CETP activity and plasma high-density lipoprotein in European populations. The EARS Group.
European journal of clinical investigation 1999;29(2):116-28.
1999: AO Rantala; Heikki Kauma; M Lilja; Markku Savolainen; A Reunanen; Y Antero Kesäniemi
Prevalence of the metabolic syndrome in drug-treated hypertensive patients and control subjects.
Journal of internal medicine 1999;245(2):163-74.
1998: Y Antero Kesäniemi
Relevance of the reduction of triglycerides in the prevention of coronary heart disease.
Current opinion in lipidology 1998;9(6):571-4.
1998: Mikko Syvänne; Markku S Nieminen; M Heikki Frick; Heikki Kauma; Silja Majahalme; Vesa Virtanen; Y Antero Kesäniemi; Amos Pasternack; Christian Ehnholm; Marja-Riitta Taskinen
Associations between lipoproteins and the progression of coronary and vein-graft atherosclerosis in a controlled trial with gemfibrozil in men with low baseline levels of HDL cholesterol.
Circulation 1998;98(19):1993-9.
1998: Heikki Kauma; Markku Savolainen; AO Rantala; M Lilja; Kari Kervinen; A Reunanen; Y Antero Kesäniemi
Apolipoprotein E phenotype determines the effect of alcohol on blood pressure in middle-aged men.
American journal of hypertension 1998;11(11 Pt 1):1334-43.
1998: Markku Päivänsalo; Jukka Merikanto; Markku Savolainen; M Lilja; AO Rantala; Heikki Kauma; A Reunanen; Y Antero Kesäniemi; Ilkka Suramo
Effect of hypertension, diabetes and other cardiovascular risk factors on kidney size in middle-aged adults.
Clinical nephrology 1998;50(3):161-8.
1998: Tapani Rönnemaa; Jukka Marniemi; Markku Savolainen; Y Antero Kesäniemi; C Ehnholm; C Bouchard; Markku Koskenvuo
Serum lipids, lipoproteins, and lipid metabolizing enzymes in identical twins discordant for obesity.
The Journal of clinical endocrinology and metabolism 1998;83(8):2792-9.
1998: Heikki Kauma; Markku Ikäheimo; Markku Savolainen; Tiila-Riikka Kiema; AO Rantala; M Lilja; A Reunanen; Y Antero Kesäniemi
Variants of renin-angiotensin system genes and echocardiographic left ventricular mass.
European heart journal 1998;19(7):1109-17.
1998: Steve E Humphries; Le Luong; Philippa J Talmud; M Heikki Frick; Y Antero Kesäniemi; Amos Pasternack; Marja-Riitta Taskinen; Mikko Syvänne
The 5A/6A polymorphism in the promoter of the stromelysin-1 (MMP-3) gene predicts progression of angiographically determined coronary artery disease in men in the LOCAT gemfibrozil study. Lopid Coronary Angiography Trial.
Atherosclerosis 1998;139(1):49-56.
1998: AO Rantala; Markku Päivänsalo; Heikki Kauma; M Lilja; Markku Savolainen; A Reunanen; Y Antero Kesäniemi
Hyperinsulinemia and carotid atherosclerosis in hypertensive and control subjects.
Diabetes care 1998;21(7):1188-93.
1998: M Johanna Liinamaa; Y Antero Kesäniemi; Markku Savolainen
Lipoprotein composition influences cholesteryl ester transfer in alcohol abusers.
Annals of medicine 1998;30(3):316-22.
1998: SM Pikkujämsä; Heikki V Huikuri; K E Juhani Airaksinen; AO Rantala; Heikki Kauma; M Lilja; Markku Savolainen; Y Antero Kesäniemi
Heart rate variability and baroreflex sensitivity in hypertensive subjects with and without metabolic features of insulin resistance syndrome.
American journal of hypertension 1998;11(5):523-31.
1998: Y Antero Kesäniemi
Guidelines for methods to determine efficacy and safety of drugs acting on the gastrointestinal tract. The international union of pharmacology (IUPHAR).
The American journal of cardiology 1998;81(8A):27F-28F.
1998: M Paassilta; Kari Kervinen; Markku Linnaluoto; Y Antero Kesäniemi
Alcohol withdrawal-induced change in lipoprotein(a): association with the growth hormone/insulin-like growth factor-I (IGF-I)/IGF-binding protein-1 (IGFBP-1) axis.
Arteriosclerosis, thrombosis, and vascular biology 1998;18(4):650-4.
1998: Kari Kervinen; Jaakko Kaprio; Markku Koskenvuo; J Juntunen; Y Antero Kesäniemi
Serum lipids and apolipoprotein E phenotypes in identical twins reared apart.
Clinical genetics 1998;53(3):191-9.
1998: Y Antero Kesäniemi
Serum triglycerides and clinical benefit in lipid-lowering trials.
The American journal of cardiology 1998;81(4A):70B-73B.
1998: M Paassilta; Kari Kervinen; AO Rantala; Markku Savolainen; M Lilja; A Reunanen; Y Antero Kesäniemi
Social alcohol consumption and low Lp(a) lipoprotein concentrations in middle aged Finnish men: population based study.
BMJ (Clinical research ed.) 1998;316(7131):594-5.
1998: Sakari Kakko; Minna Tamminen; Y Antero Kesäniemi; Markku Savolainen
R451Q mutation in the cholesteryl ester transfer protein (CETP) gene is associated with high plasma CETP activity.
Atherosclerosis 1998;136(2):233-40.
1997: M Johanna Liinamaa; Minna L Hannuksela; Y Antero Kesäniemi; Markku Savolainen
Altered transfer of cholesteryl esters and phospholipids in plasma from alcohol abusers.
Arteriosclerosis, thrombosis, and vascular biology 1997;17(11):2940-7.
1997: Anna H Karjalainen; Jorma Heikkinen; Markku Savolainen; Ann-Christine Bäckström; M Salinto; Y Antero Kesäniemi
Metabolic changes induced by peroral oestrogen and transdermal oestradiol gel therapy.
British journal of obstetrics and gynaecology 1997;104 Suppl 16():38-43.
1997: Johanna Kuusisto; Keijo Koivisto; Leena Mykkänen; Eeva-Liisa Helkala; Matti Vanhanen; Tuomo Hänninen; Kari Kervinen; Y Antero Kesäniemi; PJ Riekkinen; Markku Laakso
Association between features of the insulin resistance syndrome and Alzheimer's disease independently of apolipoprotein E4 phenotype: cross sectional population based study.
BMJ (Clinical research ed.) 1997;315(7115):1045-9.
1997: M Heikki Frick; Mikko Syvänne; Markku S Nieminen; Heikki Kauma; Silja Majahalme; Vesa Virtanen; Y Antero Kesäniemi; Amos Pasternack; Marja-Riitta Taskinen
Prevention of the angiographic progression of coronary and vein-graft atherosclerosis by gemfibrozil after coronary bypass surgery in men with low levels of HDL cholesterol. Lopid Coronary Angiography Trial (LOCAT) Study Group.
Circulation 1997;96(7):2137-43.
1997: Arja Korhonen; Mika Ala-Korpela; M Johanna Liinamaa; Jukka Jokisaari; Y Antero Kesäniemi; Markku Savolainen
Assessment of cholesteryl ester transfer protein function in lipoprotein mixtures by 1H NMR spectroscopy.
NMR in biomedicine 1997;10(7):303-8.
1997: M I J Uusitupa; Tatu A Miettinen; Essi S Sarkkinen; E Ruuskanen; Kari Kervinen; Y Antero Kesäniemi
Lathosterol and other non-cholesterol sterols during treatment of hypercholesterolaemia with beta-glucan-rich oat bran.
European journal of clinical nutrition 1997;51(9):607-11.
1997: M Johanna Liinamaa; Kari Kervinen; Minna L Hannuksela; Y Antero Kesäniemi; Markku Savolainen
Effect of apolipoprotein E phenotype on plasma lipids and lipoproteins in alcohol abusers.
Alcoholism, clinical and experimental research 1997;21(4):606-12.
1997: Leila J Karhunen; Anja Franssila-Kallunki; Aila Rissanen; Kari Kervinen; Y Antero Kesäniemi; Matti Uusitupa
Determinants of resting energy expenditure in obese non-diabetic caucasian women.
International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity 1997;21(3):197-202.
1997: Mikko Syvänne; Marja-Riitta Taskinen; V Manninen; Y Antero Kesäniemi; Amos Pasternack; J W Nawrocki; H Haber; M Heikki Frick
A study to determine the response of coronary atherosclerosis to raising low high density lipoprotein cholesterol with a fibric-acid derivative in men after coronary bypass surgery. The rationale, design, and baseline characteristics of the LOCAT Study. Lopid Coronary Angiography Trial.
Controlled clinical trials 1997;18(1):93-119.
1997: Maire Rantala; Markku Savolainen; Kari Kervinen; Y Antero Kesäniemi
Apolipoprotein E phenotype and diet-induced alteration in blood pressure.
The American journal of clinical nutrition 1997;65(2):543-50.
1996: T Korhonen; Markku Savolainen; M Juhani Koistinen; Markku Ikäheimo; Markku Linnaluoto; K Kervinen; Y Antero Kesäniemi
Association of lipoprotein cholesterol and triglycerides with the severity of coronary artery disease in men and women.
Atherosclerosis 1996;127(2):213-20.
1996: Tiila-Riikka Kiema; Heikki Kauma; AO Rantala; M Lilja; A Reunanen; Y Antero Kesäniemi; Markku Savolainen
Variation at the angiotensin-converting enzyme gene and angiotensinogen gene loci in relation to blood pressure.
Hypertension 1996;28(6):1070-5.
1996: Heikki Kauma; Markku Päivänsalo; Markku Savolainen; AO Rantala; Tiila-Riikka Kiema; M Lilja; A Reunanen; Y Antero Kesäniemi
Association between angiotensin converting enzyme gene polymorphism and carotid atherosclerosis.
Journal of hypertension 1996;14(10):1183-7.
1996: Minna Tamminen; Sakari Kakko; Y Antero Kesäniemi; Markku Savolainen
A polymorphic site in the 3' untranslated region of the cholesteryl ester transfer protein (CETP) gene is associated with low CETP activity.
Atherosclerosis 1996;124(2):237-47.
1996: Heikki V Huikuri; SM Pikkujämsä; K E Juhani Airaksinen; Markku Ikäheimo; AO Rantala; Heikki Kauma; M Lilja; Y Antero Kesäniemi
Sex-related differences in autonomic modulation of heart rate in middle-aged subjects.
Circulation 1996;94(2):122-5.
1996: J S Perkiömäki; Markku Ikäheimo; SM Pikkujämsä; AO Rantala; M Lilja; Y Antero Kesäniemi; Heikki V Huikuri
Dispersion of the QT interval and autonomic modulation of heart rate in hypertensive men with and without left ventricular hypertrophy.
Hypertension 1996;28(1):16-21.
1996: K Kervinen; H Södervik; Jyrki T Mäkelä; Juhani Lehtola; M Niemi; MI Kairaluoma; Y Antero Kesäniemi
Is the development of adenoma and carcinoma in proximal colon related to apolipoprotein E phenotype?
Gastroenterology 1996;110(6):1785-90.
1996: Y Antero Kesäniemi
Genetics and cholesterol metabolism.
Current opinion in lipidology 1996;7(3):124-31.
1996: Seppo E Niemelä; Tuomo J Karttunen; T Korhonen; E Läärä; R Karttunen; Markku Ikäheimo; Y Antero Kesäniemi
Could Helicobacter pylori infection increase the risk of coronary heart disease by modifying serum lipid concentrations?
Heart (British Cardiac Society) 1996;75(6):573-5.
1996: Heikki V Huikuri; Antti Ylitalo; SM Pikkujämsä; Markku Ikäheimo; K E Juhani Airaksinen; AO Rantala; M Lilja; Y Antero Kesäniemi
Heart rate variability in systemic hypertension.
The American journal of cardiology 1996;77(12):1073-7.
1996: Minna L Hannuksela; M Rantala; Y Antero Kesäniemi; Markku Savolainen
Ethanol-induced redistribution of cholesteryl ester transfer protein (CETP) between lipoproteins.
Arteriosclerosis, thrombosis, and vascular biology 1996;16(2):213-21.
1996: Heikki Kauma; Markku Savolainen; R Heikkilä; AO Rantala; M Lilja; A Reunanen; Y Antero Kesäniemi
Sex difference in the regulation of plasma high density lipoprotein cholesterol by genetic and environmental factors.
Human genetics 1996;97(2):156-62.
1995: Markku Savolainen; Y Antero Kesäniemi
Effects of alcohol on lipoproteins in relation to coronary heart disease.
Current opinion in lipidology 1995;6(4):243-50.
1995: S Hörkkö; Kerttu Huttunen; Y Antero Kesäniemi
Decreased clearance of low-density lipoprotein in uremic patients under dialysis treatment.
Kidney international 1995;47(6):1732-40.
1995: O Ukkola; Markku Savolainen; Pasi Salmela; K von Dickhoff; Tiila-Riikka Kiema; Y Antero Kesäniemi
Insertion/deletion polymorphism in the angiotensin-converting enzyme gene associated with macroangiopathy and blood pressure in patients with non-insulin-dependent diabetes mellitus.
Journal of molecular medicine (Berlin, Germany) 1995;73(6):307-11.
1995: O Ukkola; Markku Savolainen; Pasi Salmela; K von Dickhoff; Y Antero Kesäniemi
DNA polymorphisms at the lipoprotein lipase gene are associated with macroangiopathy in type 2 (non-insulin-dependent) diabetes mellitus.
Atherosclerosis 1995;115(1):99-105.
1995: Tatu Juvonen; Markku Savolainen; MI Kairaluoma; L H Lajunen; S E Humphries; Y Antero Kesäniemi
Polymorphisms at the apoB, apoA-I, and cholesteryl ester transfer protein gene loci in patients with gallbladder disease.
Journal of lipid research 1995;36(4):804-12.
1995: T Korhonen; Markku Savolainen; T Jääskeläinen; Y Antero Kesäniemi
Effect of a synthetic prostaglandin E2 analogue, RS-86505-007, on plasma lipids and lipoproteins in patients with moderate hypercholesterolaemia: efficacy and tolerance of treatment and response in different apolipoprotein polymorphism groups.
European journal of clinical pharmacology 1995;48(2):97-102.
1994: Mika Ala-Korpela; Arja Korhonen; J Keisala; S Hörkkö; P Korpi; L P Ingman; J Jokisaari; Markku Savolainen; Y Antero Kesäniemi
1H NMR-based absolute quantitation of human lipoproteins and their lipid contents directly from plasma.
Journal of lipid research 1994;35(12):2292-304.
1994: Minna L Hannuksela; M Johanna Liinamaa; Y Antero Kesäniemi; Markku Savolainen
Relation of polymorphisms in the cholesteryl ester transfer protein gene to transfer protein activity and plasma lipoprotein levels in alcohol drinkers.
Atherosclerosis 1994;110(1):35-44.
1994: O Ukkola; Markku Savolainen; Pasi Salmela; K von Dickhoff; Y Antero Kesäniemi
DNA polymorphisms at the locus for human cholesteryl ester transfer protein (CETP) are associated with macro- and microangiopathy in non-insulin-dependent diabetes mellitus.
Clinical genetics 1994;46(3):217-27.
1994: S Hörkkö; Kerttu Huttunen; E Läärä; K Kervinen; Y Antero Kesäniemi
Effects of three treatment modes on plasma lipids and lipoproteins in uraemic patients.
Annals of medicine 1994;26(4):271-82.
1994: Raimo Kettunen; Olli Vuolteenaho; O Ukkola; M Lilja; A Jounela; Y Antero Kesäniemi; J Leppäluoto; J Heikkilä
Effects of early administration of enalapril on radionuclide left ventricular ejection fraction and plasma N-terminal atrial natriuretic peptide after acute myocardial infarction.
The American journal of cardiology 1994;73(12):865-7.
1994: S Hörkkö; Kerttu Huttunen; K Kervinen; Y Antero Kesäniemi
Decreased clearance of uraemic and mildly carbamylated low-density lipoprotein.
European journal of clinical investigation 1994;24(2):105-13.
1994: S Hörkkö; Kerttu Huttunen; T Korhonen; Y Antero Kesäniemi
Decreased clearance of low-density lipoprotein in patients with chronic renal failure.
Kidney international 1994;45(2):561-70.
1994: K Kervinen; Markku Savolainen; J Salokannel; A Hynninen; J Heikkinen; Christian Ehnholm; M Juhani Koistinen; Y Antero Kesäniemi
Apolipoprotein E and B polymorphisms--longevity factors assessed in nonagenarians.
Atherosclerosis 1994;105(1):89-95.
1993: K Kervinen; Markku Savolainen; J I Heikkilä; Y Antero Kesäniemi
Lovastatin enhances hepatic uptake of low density lipoprotein in humans.
Journal of lipid research 1993;34(11):1975-82.
1993: O Ukkola; Markku Savolainen; Pasi Salmela; K von Dickhoff; Y Antero Kesäniemi
Apolipoprotein B gene DNA polymorphisms are associated with macro- and microangiopathy in non-insulin-dependent diabetes mellitus.
Clinical genetics 1993;44(4):177-84.
1993: Tatu Juvonen; K Kervinen; MI Kairaluoma; L H Lajunen; Y Antero Kesäniemi
Gallstone cholesterol content is related to apolipoprotein E polymorphism.
Gastroenterology 1993;104(6):1806-13.
1993: O Ukkola; K Kervinen; Pasi Salmela; K von Dickhoff; Markku Laakso; Y Antero Kesäniemi
Apolipoprotein E phenotype is related to macro- and microangiopathy in patients with non-insulin-dependent diabetes mellitus.
Atherosclerosis 1993;101(1):9-15.
1993: Mika Ala-Korpela; Yrjö Hiltunen; J Jokisaari; Sinikka Eskelinen; K Kiviniity; Markku Savolainen; Y Antero Kesäniemi
A comparative study of 1H NMR lineshape fitting analyses and biochemical lipid analyses of the lipoprotein fractions VLDL, LDL and HDL, and total human blood plasma.
NMR in biomedicine 1993;6(3):225-33.
1992: Y Antero Kesäniemi; M Lilja; K Kervinen; AO Rantala
Multiple metabolic syndrome: aspects of genetic epidemiology and molecular genetics.
Annals of medicine 1992;24(6):461-4.
1992: Minna L Hannuksela; Y Antero Kesäniemi; Markku Savolainen
Evaluation of plasma cholesteryl ester transfer protein (CETP) activity as a marker of alcoholism.
Alcohol and alcoholism (Oxford, Oxfordshire) 1992;27(5):557-62.
1992: Minna L Hannuksela; Y L Marcel; Y Antero Kesäniemi; Markku Savolainen
Reduction in the concentration and activity of plasma cholesteryl ester transfer protein by alcohol.
Journal of lipid research 1992;33(5):737-44.
1992: S Hörkkö; Markku Savolainen; K Kervinen; Y Antero Kesäniemi
Carbamylation-induced alterations in low-density lipoprotein metabolism.
Kidney international 1992;41(5):1175-81.
1991: K Kervinen; Markku Savolainen; M J Tikkanen; Y Antero Kesäniemi
Low density lipoprotein derivatization by acetaldehyde affects lysine residues and the B/E receptor binding affinity.
Alcoholism, clinical and experimental research 1991;15(6):1050-5.
1991: K Kervinen; Markku Savolainen; Y Antero Kesäniemi
Multiple changes in apoprotein B containing lipoproteins after ethanol withdrawal in alcoholic men.
Annals of medicine 1991;23(4):407-13.
1991: Yrjö Hiltunen; Mika Ala-Korpela; J Jokisaari; Sinikka Eskelinen; K Kiviniitty; Markku Savolainen; Y Antero Kesäniemi
A lineshape fitting model for 1H NMR spectra of human blood plasma.
Magnetic resonance in medicine : official journal of the Society of Magnetic Resonance in Medicine / Society of Magnetic Resonance in Medicine 1991;21(2):222-32.
1991: Y Antero Kesäniemi; M Lilja
Hypertension, plasma lipids and antihypertensive drugs.
Annals of medicine 1991;23(3):347-51.
1991: Markku Savolainen; T Korhonen; K Aalto-Setälä; Kimmo Kontula; Y Antero Kesäniemi
Screening for a prevalent LDL receptor mutation in patients with severe hypercholesterolaemia.
Human genetics 1991;87(2):125-8.
1991: Y Antero Kesäniemi
Mechanisms of low density lipoprotein lowering by hypolipidemic agents.
Annals of medicine 1991;23(2):195-8.
1991: Markku Savolainen; M Rantala; K Kervinen; L Järvi; K Suvanto; T Rantala; Y Antero Kesäniemi
Magnitude of dietary effects on plasma cholesterol concentration: role of sex and apolipoprotein E phenotype.
Atherosclerosis 1991;86(2-3):145-52.
1991: Y Antero Kesäniemi; Tatu A Miettinen
Inhibition of cholesterol absorption by neomycin, benzodiazepine derivatives and ketoconazole.
European journal of clinical pharmacology 1991;40 Suppl 1():S65-7.
1991: K Kervinen; Markku Savolainen; Y Antero Kesäniemi
A rapid increase in lipoprotein (a) levels after ethanol withdrawal in alcoholic men.
Life sciences 1991;48(22):2183-8.
1990: Markku Savolainen; Minna L Hannuksela; Seppo Seppänen; K Kervinen; Y Antero Kesäniemi
Increased high-density lipoprotein cholesterol concentration in alcoholics is related to low cholesteryl ester transfer protein activity.
European journal of clinical investigation 1990;20(6):593-9.
1989: Kimmo J Mattila; Markku S Nieminen; Ville Valtonen; V P Rasi; Y Antero Kesäniemi; S L Syrjälä; P S Jungell; M Isoluoma; K Hietaniemi; M J Jokinen
Association between dental health and acute myocardial infarction.
BMJ (Clinical research ed.) 1989;298(6676):779-81.